SELECTIVE DEPLETION OF TUMOR-SPECIFIC REGULATORY T CELLS IN COMBINATION WITH LOW DOSE CHEMOTHERAPY WITH OR WITHOUT PD-1 BLOCKADE IMPROVES ANTI-TUMOR T CELL RESPONSES IN SOLID TUMORS

被引：0
|
作者：
Axe, Dorothee Saddier [1 ]
Kuhne, Michelle [1 ]
Jain, Renu [1 ]
Weist, Brian [1 ]
机构：
[1] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0807
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
807
引用
收藏
页码：A843 / A843
页数：1
相关论文
共 50 条
  • [21] Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia and renal carcinoma
    Matejkova, Eva
    Kyjovska, Drahomira
    Michalek, Jaroslav
    Vidlakova, Petra
    CLINICAL IMMUNOLOGY, 2007, 123 : S106 - S107
  • [22] Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia and renal carcinoma
    Matejkova, Eva
    Buresova, Ivana
    Vidlakova, Petra
    Kyjovska, Drahomira
    Vitetta, Ellen S.
    Michalek, Jaroslav
    BLOOD, 2007, 110 (11) : 954A - 955A
  • [23] Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
    Okada, Masahiro
    Chikuma, Shunsuke
    Kondo, Taisuke
    Hibino, Sana
    Machiyama, Hiroaki
    Yokosuka, Tadashi
    Nakano, Miyako
    Yoshimura, Akihiko
    CELL REPORTS, 2017, 20 (05): : 1017 - 1028
  • [24] Clonal deletion of tumor-specific T cells by combination checkpoint blockade compromises antitumor efficacy in low tumor burden states
    Pai, Chien-Chun Steven
    Lu, Xiaoqing
    Simons, Donald
    DuPage, Michel
    Roybal, Kole T.
    Chen, Mingyi
    Kwek, Serena
    Casbon, Amy-Jo
    Kinsbury, Gillian A.
    Fong, Lawrence
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Differential modulation of the PD-1 pathway impacts the anti-tumor activity of CAR T cells
    Lin, Regina J.
    Gautron, Anne-Sophie
    Poirot, Laurent
    Wong, Oi Kwan
    Sasu, Barbra
    Boldajipour, Bijan
    CANCER RESEARCH, 2017, 77
  • [26] Improved T cell restoration by depletion of T regulatory (Treg) cells followed by PD-1 blockade during chronic infection
    Penaloza-MacMaster, Pablo
    Araki, Koichi
    Ahmed, Rafi
    West, Erin
    Freeman, Gordon
    Rudenski, Alexander
    Tan, Wendy
    Jin, H.
    Aubert, Rachael
    Omara, Leigh
    Iyer, Smita
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [27] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    NANO TODAY, 2022, 46
  • [28] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    Nano Today, 2022, 46
  • [29] SELECTIVE TARGETING OF GARP-LTGFß AXIS IN THE TUMOR MICROENVIRONMENT AUGMENTS PD-1 BLOCKADE VIA ENHANCING CD8+ T CELL ANTI-TUMOR IMMUNITY
    Li, Anqi
    Chang, Yuzhou
    Song, No-Joon
    Wu, Xingjun
    Chung, Dongjun
    Riesenberg, Brian
    Velegraki, Maria
    Kwon, Hyunwoo
    Chakravarthy, Karthik
    Bolyard, Chelsea
    Wang, Yi
    Ma, Qin
    Li, Zihai
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A876 - A876
  • [30] Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?
    Hua-Yu Yang
    Le-Jia Sun
    Yi-Lei Mao
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (02) : 93 - 94
12345